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EXTRAGENITOURINARY NEPHROGENIC METAPLASIA / ADENOMA
PRESENTING AS OVERACTIVE BLADDER SYNDROME e A CASE REPORT
AND LITERATURE REVIEW
Meng-Lin Chang 1,2, Shih-Chang Fuh 3, Ting-Jui Chang 4, Hsiao-Yu
Lin 1. 1Department of Urology, Taipei Medical University Hospital, Taipei
110, Taiwan; 2Department of Urology, Keelung Hospital, Ministry of Health
and Welfare, Taiwan; 3Department of Urology, Taoyuan Hospital, Ministry
of Health and Welfare, Taiwan; 4Department of Urology, Tainan Municipal
Hospital, Taiwan
Background: Overactive bladder (OAB) is a syndrome that causes sudden
and unstoppable feeling to urinate. According to International Continence
Society (ICS) 2010, OAB is deﬁned as urinary urgency, usually with urinary
frequency and nocturia, with or without urgency urinary incontinence.
Mainstay treatment of OAB is anticholinergics and beta-3 adrenergic
agonist is a new direction of OAB management.
Case Report: We present a 49-year-old female patient with urgency,
frequency, and nocturia. Urinalysis showed no pyuria but microscopic
hematuria (WBC 0-2, RBC 2-5). Anticholinergic was prescribed and there
was little improvement after two weeks treatment. Suprapubic sonog-
raphy is performed and showed residual urine 160ml and a 4.3 x 4.1 cm
sized cystic mass, which protruded into bladder trigone. She then was
transferred to GYN for study the nature of the mass. Per-vaginal exami-
nation is normal and trans-vaginal sonography showed no abnormality in
vagina, cervix, uterus, except a cystic mass between vagina and bladder.
Cystoscopy was performed and showed intact mucosa in urethra, bladder
neck, and bladder. Computed tomography showed 4.1 x 4.3 x 3.3 cm sized
multi-sepatated cystic space-occupying lesion causing posterior
compression of vagina, anterior compression of base of urinary bladder,
suspect abscess. Beta iodine was injected into the mass and there was no
connection to urinary tract or to vagina. Operative management was
carried out in two stages. In stage one, marsupialization was performed.
The ﬂuid inside the cystic mass was clear yellowish ﬂuid. Analysis of the
ﬂuid showed elevated creatinine, and ﬂuid cytology showed atypical cell.
After three weeks, no signiﬁcant shrinkage happened on sono and we
performed total excision of cystic mass through vaginal approach. Care-
fully dissection was carried out to prevent injury to urethra, bladder neck
and bladder base. Foley catheter was placed for two weeks. After
removing Foley catheter, the symptoms of urgency, frequency and noc-
turia were gone and residual urine after voiding decreased to less than
20ml. Pathological ﬁnding of excised mass revealed nephrogenic meta-
plasia /adenoma.
Discussion: Nephrogenic metaplasia / adenoma is a rare benign lesion and
is usually found within genitourinary tract (ureter and bladder). There are
also rare case reports that nephrogenic metaplasia / adenoma is found in
renal cortical cyst, urethral diverticulum (usually in female). Nephrogenic
metaplasia / adenoma is considered to be relatedwith chronic inﬂammation
secondary to genitourinary trauma, prior surgery, renal calculi, or repeated
instrumentation. In our case, the tumor is outside urinary tract without
connection to bladder or vagina. The mass effects between bladder and
vagina may contribute to overactive bladder syndrome. Hence, we recom-
mend initial evaluation of female overactive bladder syndrome should
include detailed physical pelvic examination and ultrasound investigation.Pediatrics
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ONE STAGE RECONSTRUCTION IN AMBIGEOUS GENITALIA IN MIXED
GONADAL DYSGENESIS: CASE REPORT
Hueih-Shing Hsu, Shyh-Chyi Chang, Hsu-Hsiang Wang, Heng-Chang
Chuang, I-Hung Shao. Division of Urology, Department of Surgery, Lotung
Pohai Hospital Yilan, Taiwan
Case: This is a 17 months old child, physical examination showed asym-
metry of scrotum with severe hypospadias. The child received bilateral
hernia repair at 2 months old. The chromosome study showed 45XO and
46XY. Hormone study revealed 17-OH progesterone is 10.8 ng/ml (0.12-
8.4), cortisol is 2.38 ug/ml (8-28), testosterone is 1.81 ng/ml (<0.2) renin is117 IU/ml（7-76）, ACTH is 38.6 pg/ml (9-52). Image showed low entry of
urogenital sinus. We performed clitoplasty and vaginoplaty in one stage.
Laparoscopic gonadectomy for ovotestis and streak gonad was also done at
the same time.
Discussion: The incidence of malignancy in streak gonad is 15-25% espe-
cially with Y chromosome exists. The child will be infertile and female
gender is preferred. One stage reconstruction included gonadectomy, cli-
toplasty and vaginoplasty.
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CONGENITAL MESOBLASTIC NEPHROMA IN A PREMATURE NEONATE: A
CASE REPORT AND A REVIEW OF LITERATURE
Ellen Wong, Hong-Lin Cheng. Department of Urology, National Cheng Kung
University College of Medicine and Hospital, Tainan, Taiwan
Congenital mesoblastic nephroma (CMN), although a rare tumor, is the
most common neonatal renal tumor which accounts for 3-10% of child-
hood renal tumors. Currently, it can usually be detected antenatally with
judicious and common use of ultrasonography. Surgical resection with
nephrectomy is considered an adequate therapy for all subtypes. We re-
ported a case of antenetal detection of renal tumor via ultrasonography
and was diagnosed of congenital mesoblastic nephroma after radical
neprectomy when he was 8 days old.
Case presentation：A premature male infant was born to a G1P1, 31-year-
old woman after 32+6 weeks' gestation, which was complicated by poly-
hydramnios, detected on antenatal scan since 28 weeks. Later level II ul-
trasound further revealed fetal left renal mass, 6.4x5.9x5.2 cm in size.
Preterm labor was noted at 31 weeks, followed by delivery by cesarean
section due to progressive polyhydramnios after tocolysis for one more
week. The babywas born in good condition, with Apgar scores of 9 and 9 at
1 and 5 minutes respectively. Birth weight was 1802 gm. Physical exami-
nation at birth was reported normal. On admission to the NICU, there
were no cardiorespiratory concerns apart from an initial blood pressure of
75/36 mmHg. Abdominal CT showed left renal heterogeneous tumor
involving upper and middle poles with perirenal ﬂuid collection and
enhanced Georta's fascia. There was no obvious intratumoral calciﬁcation
or fat components. Operation as left radical nephrectomy was done and
formal pathology conﬁrmed the diagnosis of congenital mesoblastic
nephroma.
Conclusion：Despite being uncommon, CMN should be always taken into
consideration when evaluating a fetal abdominal mass. Completeness of
tumor resection is extremely important and is the primary treatment. Tthe
overall prognosis of CMN is fairly good.Other
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THULIUM LASER URETEROTOMY FOR TREATMENT OF URETERAL
STENOSIS
Guang-Dar Juang 1, Thomas I-sheng Hwang 1,2,3, Te-Fu Tsai 1. 1Division of
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Purpose: We describes the preliminary experience of a new method by
Thulium laser for failed ureteral stenotic treatment.
Materials and Methods: Between 2012 and 2014, a total of 9 patients of
failed previous treatment for ureteral stenosis were managed by Thulium
Laser endoureterotomy. An 8-10 watts Thulium laser power was used to
incise open the stenotic ureter by 300-microm ﬁber through ureteroscopy.
Double J catheter of 8 Fr. were used for post-incisional stenting. The mean
follow-up time was 8.4 months. Successful treatment was deﬁned as no
obstructive uropathy on an imaging study, being free of associated
symptoms, at follow-up period.
Results: Successful treatment was observed in 6 patients (66.7%). Three
patients (33.3%) had recurrent ureteral stricture, receiving long-term
double J stenting. No procedural-related complications have been noted.
Conclusion: In our limited experience, Thulium laser ureterotomy is a safe
and feasible method for ureteral stenosis with failed previous treatment.
